Italy, one of the countries with the biggest losses in the world due to the new type of coronavirus, claimed that it developed the first COVID-19 vaccine. The vaccine, which is said to have been developed in a laboratory setting by Italian scientists, was tested at the Spallanzani Hospital in the capital city of Rome. Scientists suggest that the vaccine is one of the most advanced vaccines ever, as it has the ability to neutralize SARS-CoV-2 found in human cells. The scientists who made comparisons by trying five different vaccine candidates developed on mice selected the two best candidates after the observations. At this point, the researchers say that after a single vaccination, experimental mice have developed antibodies that can prevent the new type of coronavirus from infecting human cells. Vaccination studies continue in different parts of the world: Vaccination studies developed against COVID-19 all over the world continue. One of the news that had a wide coverage in the world press recently came from Oxford University in England. Within the scope of the vaccine trials that started with the first 2 volunteers, one person was injected with the COVID-19 vaccine and the other with meningitis vaccine for control purposes. Apart from the vaccine, another method that stands out in the treatment process of the virus is plasma therapy. In this treatment method, which is also applied in our country, the fluid called ‘plasma’, taken from the blood of people who were previously diagnosed with COVID-19 and recovered after the treatment process, is injected into the patients in intensive care unit and helps the patient to start his passive immunity. Malaria drugs are said to be effective against the virus: Another thing that is said to be effective when used in very low doses against the virus is malaria medications. According to reports from China, malaria medication, which helps the recovery of COVID-19 patients, helps to shorten the cough, cold and fever period according to some study results. According to a report published in the New England Journal of Medicine (NEJM), promising malaria medication does not show any positive or negative effects in mild to moderate patients. The rate of recovery is higher in patients who are taking Remdesivir: Remdesivir, a drug used in the treatment of MERS and SARS, the diseases caused by the coronavirus family, was produced in 2014 for Ebola treatment. The drug, which is claimed to speed up the healing process in COVID-19 disease, has gained popularity recently. According to a clinical study, healing time in patients using Remdesivir is 31% faster than placebo treatment. On the other hand, it is also known that the 8% mortality rate observed in patients taking Remdesivir is partially lower than the patients receiving placebo, which is around 11.6%.
